Could gene therapy be the key to a fast coronavirus vaccine?

Could gene therapy be the key to a fast coronavirus vaccine?

It generally takes a decade to bring a new drug candidate from the initial research phase to final market approval. This is a painstakingly long process, and especially during fast moving pandemics as we currently witness with the novel coronavirus, one might wonder how this timeline could be shortened.

Read more

MyCellHub raises € 1.1 million to help biotech companies manage production data

MyCellHub, an innovative data management and analytics platform for the production of biopharmaceuticals such as cell and immune therapies raises €1,1 million by Noshaq, The Faktory, Gemma Frisius Fund and The CoFoundry. The investment will help the KU Leuven spin-off to accelerate the launch of the platform. The MyCellHub ‘software as a service’ platform is an app that uses interactive work instructions to assist operators in sterile production environments and which automates data collection and reporting tasks. This provides significant efficiency gains, especially as more than 90% of bio-manufacturers still report their processes on paper.

Read more